In the wake of the increase in Current Liabilities in the third quarter 2024, Quick Ratio fell to 1.03 below Cutera Inc average.

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Quick Ratio than Cutera Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 638 to 1926.

Explain Quick Ratio?
How much Cash & cash equivalents CUTR�s has?
What are CUTR�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CUTR Quick Ratio	(Sep 30 2024) Q3	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4	(Sep 30 2023) Q3
Y / Y Current Liabilities Change	15.65 %	-33.94 %	-44.31 %	92.65 %	-0.83 %
Y / Y Cash & cash equivalent Change	-67.91 %	-64.56 %	-60.6 %	-54.74 %	-28.43 %
Quick Ratio MRQ	1.03	2.53	3.76	1.53	3.73
CUTR's Total Ranking	# 1926	# 638	# 1060	# 977	# 1366
Seq. Current Liabilities Change	69.75 %	16.93 %	-70.17 %	95.35 %	-3.03 %
Seq. Cash & cash equivalent Change	-30.68 %	-21.18 %	-26.58 %	-20 %	-23.46 %

Quick Ratio third quarter 2024 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 117
Healthcare Sector	# 700
Overall Market	# 1926

Quick Ratio Statistics
High	Average	Low
10.87	2.76	0.37
(Dec 31 2010)		(Mar 31 2020)

Financial Statements
Cutera Inc 's Current Liabilities	$ 56 Millions	Visit CUTR's Balance sheet
Cutera Inc 's Cash & cash equivalent	$ 58 Millions	Visit CUTR's Balance sheet
Source of CUTR's Sales		Visit CUTR's Sales by Geography

Cumulative Cutera Inc 's Quick Ratio

CUTR's Quick Ratio for the trailling 12 Months

CUTR Quick Ratio	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months
Y / Y Current Liabilities TTM Growth	6.9 %	2.87 %	17.35 %	47.47 %	41.22 %
Y / Y Cash & cash equivalent TTM Growth	-60.98 %	-52.19 %	-40.47 %	-15.62 %	21.1 %
Quick Ratio TTM	1.85	2.52	3.01	3.41	5.07
Total Ranking TTM	# 3332	# 1701	# 3312	# 3082	# 1050
Seq. Current Liabilities TTM Growth	3.71 %	-7.66 %	-9.21 %	22.96 %	-0.2 %
Seq. Cash & cash equivalent TTM Growth	-23.82 %	-22.84 %	-19.65 %	-17.39 %	-6.66 %

Quick ratio ranking by company, industry and sector >> Back to CUTR Financial Strength Comparisons >> Go to Compare CUTR Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q3 2024 to $55.69 millions, cumulative Quick Ratio decreased to 1.85 below the Cutera Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 202 other companies have achieved higher Quick Ratio than Cutera Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 1701 to 3332.

Explain Quick Ratio?
How much Cash & cash equivalents CUTR�s has?
What are CUTR�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 203
Healthcare Sector	# 909
Within the Market	# 3332

trailing twelve months Quick Ratio Statistics
High	Average	Low
4.76	2.02	0.52
(March 31, 2014)		(Mar 31 2020)

Companies with similar Quick Ratio in the quarter ending Sep 30 2024, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2024 MRQ Cash & cash equivalent	Sep 30 2024 MRQ Current Liabilities
Tandem Diabetes Care Inc	2.81	$ 473.305 Millions	$ 168.424 Millions
Merit Medical Systems Inc	2.76	$ 523.128 Millions	$ 189.610 Millions
Intuitive Surgical Inc	2.52	$ 4,231.700 Millions	$ 1,676.800 Millions
Zynex inc	2.41	$ 37.630 Millions	$ 15.605 Millions
Inogen Inc	2.38	$ 120.663 Millions	$ 50.805 Millions
Nephros Inc	2.32	$ 2.457 Millions	$ 1.058 Millions
Solana Company	2.32	$ 3.468 Millions	$ 1.496 Millions
Sintx Technologies Inc	2.31	$ 4.814 Millions	$ 2.080 Millions
Edwards Lifesciences Corporation	2.29	$ 4,446.100 Millions	$ 1,944.100 Millions
Safe Pro Group Inc	2.23	$ 2.335 Millions	$ 1.049 Millions
Orthopediatrics Corp	2.20	$ 76.064 Millions	$ 34.625 Millions
Treace Medical Concepts Inc	2.16	$ 82.799 Millions	$ 38.263 Millions
Lifeward ltd	2.13	$ 21.306 Millions	$ 10.022 Millions
Mimedx Group Inc	2.12	$ 88.801 Millions	$ 41.941 Millions
Livanova Plc	2.05	$ 666.576 Millions	$ 324.402 Millions
Universal Biosensors Inc	1.98	$ 8.563 Millions	$ 4.322 Millions
Surmodics Inc	1.95	$ 40.112 Millions	$ 20.543 Millions
Warby Parker Inc	1.93	$ 251.032 Millions	$ 130.117 Millions
Penumbra Inc	1.90	$ 291.024 Millions	$ 153.185 Millions
Cadre Holdings inc	1.88	$ 92.989 Millions	$ 49.556 Millions
Electromed Inc	1.87	$ 13.864 Millions	$ 7.419 Millions
Jin Medical International Ltd	1.81	$ 26.757 Millions	$ 14.774 Millions
Medinotec Inc	1.79	$ 2.758 Millions	$ 1.538 Millions
Atricure Inc	1.75	$ 130.335 Millions	$ 74.431 Millions
Electrocore Inc	1.72	$ 12.947 Millions	$ 7.549 Millions
Inspira Technologies Oxy B H N Ltd	1.71	$ 5.779 Millions	$ 3.370 Millions
Nyxoah Sa	1.59	$ 38.288 Millions	$ 24.113 Millions
Lensar Inc	1.55	$ 18.080 Millions	$ 11.678 Millions
Longduoduo Co Ltd	1.53	$ 0.361 Millions	$ 0.236 Millions
Genedx Holdings Corp	1.51	$ 116.460 Millions	$ 77.342 Millions

Date modified: 2026-09-08T17:18:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.